Company Punctofarm Srl with Fiscal Code 16811467
recorded a turnover of 2024 of
300.124,
with a net profit of
14.619
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Punctofarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
130.385
126.697
148.025
170.929
180.502
216.626
232.564
256.999
258.170
300.124
Total Income - EUR
130.518
126.724
148.027
170.940
180.504
216.628
232.566
257.002
258.173
300.129
Total Expenses - EUR
131.631
132.994
147.538
165.325
175.939
203.247
226.492
243.902
246.164
282.648
Gross Profit/Loss - EUR
-1.113
-6.270
489
5.614
4.565
13.381
6.074
13.100
12.009
17.480
Net Profit/Loss - EUR
-1.477
-6.270
-865
3.898
2.743
11.369
4.245
10.933
9.676
14.619
Employees
3
3
3
3
3
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 16.9%, from 258.170 euro in the year 2023, to 300.124 euro in 2024.
The Net Profit increased by 4.997 euro, from 9.676 euro in 2023, to 14.619 in the last year.
Check the financial reports for the company - Punctofarm Srl
Financial Rating - PUNCTOFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Punctofarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Punctofarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Punctofarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
76.143 euro in 2024 which includes Inventories of
38.394 euro, Receivables of
32.881 euro and cash availability of
4.868 euro.
The company's Equity was valued at
14.703 euro, while total Liabilities amounted to
61.440 euro.
Equity increased by 3.653 euro, from 11.112 euro in 2023, to 14.703 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Punctofarm Srl